- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05452707
Task-oriented Arm/Hand Skill Rehabilitation and Therapy Dose Dimensions in Subacute Spinal Cord Injury Rehabilitation
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Annemie Spooren, Prof. Dr.
- Phone Number: +32 11 26 93 32
- Email: annemie.spooren@uhasselt.be
Study Contact Backup
- Name: Nele Bertels, MSC
- Phone Number: +32 11 26 86 92
- Email: nele.bertels@uhasselt.be
Study Locations
-
-
-
Gent, Belgium
- Recruiting
- UZ Gent
-
Leuven, Belgium
- Recruiting
- UZ Leuven - Campus Pellenberg
-
-
-
-
-
Hoensbroek, Netherlands
- Recruiting
- Zorggroep Adelante
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients during the subacute phase (0-12 months post-injury) of a spinal cord injury.
Therapists who give active training to patients in the subacute phase (0-12 months post-injury) of a spinal cord injury.
Description
Inclusion Criteria:
Primary objective
- Have sustained a traumatic or non-traumatic SCI between C1 and T1.
- Have an AIS A, B, C or D
- Are older than 16 years
- Being able to follow standard arm/hand skill training.
- Patients in the subacute phase (4-30 weeks post-injury)
- Receiving usual care
- Able to understand the purpose of the study (understanding Dutch, English, French and German).
- Secondary objective
Add patients with:
- Persons with SCI (C1-S4)
- having an AIS A, B, C, D;
- Are older than 16 years;
- Patients in the subacute phase (4-30 weeks post-injury)
- receiving standard care or more intensive care as defined by the SCI-MT trial - Therapists Physiotherapists, occupational therapists and sports therapists with at least two years of experience in SCI rehabilitation
Exclusion Criteria:
- have any significant medical or physical condition (including pregnancy) or psychiatric illness that could prevent the person from participating in the study
- are unable/unwilling to provide informed consent.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients
Patients will be observed during their active training sessions. Patients will be asked questions about:
|
There will be an observation of the usual care; no intervention will be added.
|
|
Therapists
Therapists will be asked questions about the observed training sessions of the patients. The questions will be about:
|
There will be an observation of the usual care; no intervention will be added.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Task-oriented and therapy dose dimensions and the change in time of these components in arm/hand skill training in usual care in cervical SCI during subacute rehabilitation
Time Frame: Patients will be observed for three weeks between 4 and 20 weeks post-injury. There will be three random days of observations. Data will be collected from every therapy session with at least 50% arm/hand skill training
|
|
Patients will be observed for three weeks between 4 and 20 weeks post-injury. There will be three random days of observations. Data will be collected from every therapy session with at least 50% arm/hand skill training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceived dose in spinal cord injury in the subacute rehabilitation
Time Frame: Patients will be observed for three weeks between 4 and 20 weeks post-injury. There will be three random days of observations. Data will be collected before and after every active therapy session.
|
Patients and therapists answers questions before and after the sessions Patients get questions on:
Therapists get questions on:
|
Patients will be observed for three weeks between 4 and 20 weeks post-injury. There will be three random days of observations. Data will be collected before and after every active therapy session.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pilot study: usability of evening reports in rehabilitation of SCI.
Time Frame: Patients will be observed for three weeks between 4 and 20 weeks post-injury. There will be three random days of observations. Data will be collected in the evening after the active therapy session.
|
Patients get questions on a evening report the themes are:
Patients get questions on a evening report the themes are:
|
Patients will be observed for three weeks between 4 and 20 weeks post-injury. There will be three random days of observations. Data will be collected in the evening after the active therapy session.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Annemie Spooren, Prof.Dr., UHasselt
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NB1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injuries
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingInjury, Spinal Cord
-
Universidade do Vale do ParaíbaCompletedInjuries, Spinal Cord
-
Khon Kaen UniversityUnknownInjuries, Spinal Cord
-
Institut GuttmannNot yet recruitingSpinal Cord Injury | Spinal Cord Disease | Spinal Cord Injuries (SCI) | Traumatic Spinal Cord InjuriesSpain
-
InVivo TherapeuticsTerminated
-
Ekso BionicsBurke Medical Research InstituteCompletedInjuries, Spinal CordUnited States
-
ReWalk Robotics, Inc.Unknown
-
Chang Gung Memorial HospitalNot yet recruitingSpine Injury | Complete Spinal Cord Injury | Incomplete Spinal Cord Injury | Cord Injury, Spinal | Cord Infarction Spinal
-
Shepherd Center, Atlanta GACompletedInjuries, Spinal Cord
Clinical Trials on Observation and questionnaire of active therapy
-
University of UtahNational Cancer Institute (NCI)TerminatedObstructive Sleep Apnea Syndrome | Polycythemia Vera | Essential Thrombocythemia | CALR Gene Mutation | JAK2 Gene Mutation | MPL Gene MutationUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Pathologic Stage I HPV-Mediated (p16-Positive)... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)SuspendedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | PSA Failure | PSA Progression | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8United States
-
M.D. Anderson Cancer CenterCompletedBrain CancerUnited States
-
Institute of Cancer Research, United KingdomRecruitingProstate CancerUnited Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8 | Stage II Rectal Cancer AJCC v8 | Stage IIC Rectal Cancer AJCC v8United States
-
Masaryk Memorial Cancer InstituteRecruiting
-
Kafrelsheikh UniversityCompletedHand Functions on Hemiplegic Cerebral PalsyEgypt
-
Gruppo Italiano Malattie EMatologiche dell'AdultoUnknownMyelodysplastic Syndromes | AdultBelgium, United States, Austria, United Kingdom, Italy, Taiwan, Brazil, China, Croatia, Czechia, France, Germany
-
Rennes University HospitalInstitut National de Recherche en Informatique et en AutomatiqueWithdrawnWeakness of the Lower LimbsFrance